drugset / Trial / NCT02620163
Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate efficacy and safety of YH22162 versus telmisartan / amlodipine treatment in patients with hypertension inappropriately controlled on telmisartan/amlodipine treatment
Timeline
- Start
- 2015-12
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amlodipine | Other / unclassified | 5 mg | — |
| Subject | Chlorthalidone | Other / unclassified | 12.5 mg | — |
| Subject | Chlorthalidone | Other / unclassified | 25 mg | — |
| Comparator | Telmisartan | Other / unclassified | 40 mg | — |
| Comparator | Telmisartan | Other / unclassified | 80 mg | — |